Peptide therapy TikTok claims: what the science actually supports

What's this video probably claiming?

Accounts like @peptivalabs typically run through a roster of peptides, BPC-157, TB-500, CJC-1295, ipamorelin, GHK-Cu, MK-677, and newer nootropic peptides like semax and selank, framing them as accessible biohacking tools that accelerate healing, boost growth hormone, improve cognition, and extend healthspan. The pitch usually goes something like: these are the compounds elite athletes and longevity doctors already use, and the only reason you haven't heard of them is that Big Pharma can't patent them. Expect claims about rapid tendon and gut repair from BPC-157, synergistic GH pulses from CJC-1295 plus ipamorelin stacks, and copper peptide GHK-Cu reversing skin aging at the cellular level. The MK-677 content often blurs the line between a secretagogue and actual growth hormone, which is a meaningful regulatory and physiological distinction the creator is probably not making.

What does the science actually show?

The honest answer is: it depends heavily on which peptide you're asking about, and the evidence quality ranges from genuinely interesting to nearly nonexistent in humans. BPC-157 has accumulated a reasonable rodent literature. Sikiric et al. (2018, Current Pharmaceutical Design) documented accelerated tendon-to-bone healing in rat models at doses around 10 mcg/kg, but no randomized controlled trials exist in humans. TB-500 (thymosin beta-4) similarly shows wound-healing effects in animal models and one small cardiac trial (Goldstein et al., 2012, Annals of the New York Academy of Sciences), but human data is sparse. CJC-1295 with DAC does produce sustained GH elevations. Ionescu and Frohman (2006, Journal of Clinical Endocrinology and Metabolism) showed mean GH increases of roughly 2-10 fold in healthy adults, but that study population was not people trying to add muscle mass. MK-677, an oral secretagogue, increased IGF-1 by about 60% in older adults in the Nass et al. (2008, Annals of Internal Medicine) trial, but also increased fasting glucose and caused fluid retention in a meaningful proportion of participants.

Where does the social media noise diverge from clinical reality?

Several places. First, the species gap: BPC-157 and TB-500 results come almost entirely from rodent studies, and rodent wound healing physiology is not human wound healing physiology. Translating rat tendon data into advice for a person with a torn rotator cuff is a larger leap than most TikTok peptide content acknowledges. Second, the regulatory status of these compounds matters practically. The FDA removed BPC-157 and TB-500 from the bulk drug substances list eligible for compounding in 2023, which means legally compounded versions from 503A pharmacies are no longer straightforward to obtain. Creators rarely mention this. Third, stacking multiple GH-axis peptides, say CJC-1295, ipamorelin, and MK-677 simultaneously, is not a protocol with any published human safety data. The nootropic peptides semax and selank have some Russian clinical literature suggesting anxiolytic and cognitive effects, but those trials are small, often unpublished in peer-reviewed Western journals, and used intranasal administration in ways that differ from how they're being discussed online.

What should you actually know?

Peptide therapy exists on a spectrum. Some compounds, like certain growth hormone-releasing peptides, have legitimate clinical applications and physician-supervised use cases. Others are being discussed online based almost entirely on forum anecdote and animal data extrapolated with extraordinary confidence. If you're considering any of these compounds, the relevant questions are not which YouTube protocol to follow but whether you have a clinician who can order baseline labs, monitor IGF-1 and fasting glucose, and actually adjust dosing based on your bloodwork. MK-677's glucose effects are not trivial, particularly for anyone with insulin resistance. GHK-Cu topical data is more established than systemic peptide data and carries a lower risk profile. The most responsible thing a platform or creator can do is acknowledge what we don't know, and that list is long. Be skeptical of anyone who presents this category as figured out.